Executive Order 14120-Advancing Women's Health Research and Innovation
Issued 2024-03-18 by Joseph R. Biden Jr.
Plain-English Overview
AI-generated summary explaining what this action does, who it affects, and why it matters
Executive Order 14120, signed in 2024, directs federal agencies to advance research into women's health and to improve health outcomes for women across their lifespans. The order reflects long-standing concerns that women's health — particularly conditions that disproportionately affect women, such as autoimmune diseases, cardiovascular disease, and reproductive health conditions — has been historically understudied and underfunded in medical research. It directs agencies to prioritize and expand investments in women's health research, improve data collection, and ensure that clinical trials and studies adequately represent women.
The order affects the National Institutes of Health, the Department of Health and Human Services, and other federal health research agencies. Women across the country benefit from improved research into conditions that affect them, and the medical and scientific research community is affected by new federal funding priorities and data requirements.
The constitutional basis for this order rests on the President's authority to direct the executive branch and set priorities for federally funded research. To the extent the order involves redirecting or conditioning congressionally appropriated funds, the administration would need to operate within the bounds of existing appropriations law and the Impoundment Control Act. The overall purpose — improving women's health research — is well within the executive's appropriate policy discretion.
AI-generated summary for educational purposes
Constitutional Analysis
How this action fits (or doesn't) within Article II authority and existing law
Executive Order 14120 ("Executive Order 14120-Advancing Women's Health Research and Innovation") involves withholding, pausing, or freezing federal funds. The President's stated reasoning: "that women have access to high-quality, evidence-based health care and to improve health outcomes for women across their lifespans and throughout the country." This directly implicates the Impoundment Control Act of 1974, which was passed specifically to prevent presidents from refusing to spend money Congress has appropriated. Article I, Section 9 of the Constitution grants Congress the exclusive "power of the purse."
When Congress passes an appropriations bill and the President signs it into law, the executive branch is legally obligated to spend those funds for their designated purpose. Courts have consistently held that policy disagreements do not give the President authority to unilaterally withhold congressionally appropriated money. This type of action frequently prompts litigation and has been struck down by federal courts.
Official Summary
DCPD202400208 * {margin:0; padding:0; text-indent:0; } .s1 { color: black; font-family:"Times New Roman", serif; font-style: italic; font-weight: normal; text-decoration: none; font-size: 12pt; } h1 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: bold; text-decoration: none; font-size: 12pt; } .p, p { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11pt; margin:0pt; } .s2 { color: black; font-family:"Times New Roman", serif; font-style: italic; font-weight: normal; text-decoration: none; font-size: 11pt; } .s3 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 12pt; } .s4 { color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 9pt; } li {display: block; } #l1 {padding-left: 0pt;counter-reset: c1 1; } #l1> li>*:first-child:before {counter-increment: c1; content: "("counter(c1, lower-latin)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11pt; } #l1> li:first-child>*:first-child:before {counter-increment: c1 0; } #l2 {padding-left: 0pt;counter-reset: c2 1; } #l2> li>*:first-child:before {counter-increment: c2; content: "("counter(c2, lower-roman)") "; color: black; font-family:"Times New Roman", serif; font-style: normal; font-weight: normal; text-decoration: none; font-size: 11pt; } #l2> li:first-child>*:first-child:before {counter-increment: c2 0; }